bioAffinity publishes clinical framework for CyPath Lung nodule testing
Go back to bioAffinity publishes clinical framework for CyPath Lung nodule testing| (NASDAQ: BIAF) | Delayed: 9.89 +4.54 (84.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.35 | 52 Week High | $ | |||
| Open | $7.00 | 52 Week Low | $ | |||
| Day High | $11.00 | P/E | N/A | |||
| Day Low | $6.45 | EPS | $ | |||
| Volume | 17,731,398 | |||||
| (NASDAQ: BIAFW) | Delayed: 0.25 +0.09 (56.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.16 | 52 Week High | $ | |||
| Open | $0.25 | 52 Week Low | $ | |||
| Day High | $0.41 | P/E | N/A | |||
| Day Low | $0.18 | EPS | $ | |||
| Volume | 6,219 | |||||

